Browse the full management transaction log of EQUASENS, a publicly traded company based in France. Shares are quoted on FR FR, under the authority of AMF. Operating in the Healthcare & Pharma sector, EQUASENS has logged 8 reports. Market capitalisation: €562.2m. The latest transaction was filed on 13 May 2025 — Acquisition. Among the most active insiders: Thierry CHAPUSOT. The full history is openly available.
FY ended December 2025 · cache
8 of 8 declarations
EQUASENS is a leading European provider of digital solutions for healthcare professionals. Listed on Euronext Paris under the ticker EQS and ISIN FR0012882389, the group has been built over more than 35 years around a highly specialized positioning in software, services and connected equipment for the healthcare ecosystem. Headquartered historically in Villers-lès-Nancy, it has become one of the best-known French healthcare software publishers, with deep expertise in digitizing pharmacies, healthcare institutions and independent practitioners. The group now employs more than 1,500 people across Europe and is included in the Euronext Tech Leaders segment, reinforcing its profile as a technology company with a significant recurring-revenue base. EQUASENS’ core business is the design, publishing and integration of business software, cloud services, interoperability solutions and related hardware for healthcare players. Its offering spans retail pharmacies, medical practices, care facilities, health networks and, more broadly, public and private healthcare organizations. In recent years, the group has advanced a platform strategy that goes beyond its historical software base to include higher-value services such as digital training, telehealth, SaaS solutions and sovereign healthcare data infrastructure. Recent acquisitions including Erevo, Calimed, Digipharmacie, as well as businesses related to DIS and Résurgences, illustrate a development strategy that combines organic growth with targeted bolt-on acquisitions. Geographically, EQUASENS has a strong footprint in France and an expanding European presence, with operations reported in Germany, Great Britain, Belgium, Ireland, Italy and Luxembourg. This multi-country setup enables the company to serve a diverse customer base while adapting to local healthcare workflows and regulations. In 2025, the group reported revenue of €236.5 million, up 9.1%, EBITDA of €66.7 million and net profit of €41.1 million, confirming a profitable model supported by growing recurring revenues. Its strategy is centered on innovation, the strengthening of its healthcare ecosystem and the upgrade of its service offering, making EQUASENS a structural player in the digital transformation of healthcare in Europe.